{"title":"我们是否给有高碳酸血症风险的病人提供了过多的氧气?来自一家大型教学医院的真实数据。","authors":"B Ronan O'Driscoll, Nawar Diar Bakerly","doi":"10.1016/j.rmed.2025.107965","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Oxygen guidelines recommend a target saturation range (SpO<sub>2</sub> range) of 88–92 % for patients at risk of hypercapnia. Saturations <88 % and saturations >92 % whilst using supplemental oxygen are associated with increased mortality.</div></div><div><h3>Methods</h3><div>We audited SpO<sub>2</sub> observations of all patients with a prescribed target range of 88–92 % at one hospital over a four-year period.</div></div><div><h3>Results</h3><div>Of 1,045,958 observations from patients with an oxygen prescription, 107,724 (10.3 %) had a target range of 88–92 % (at risk of hypercapnia). 26,668 of these observations (24.8 %) involved oxygen use. 89.6 % of the SpO<sub>2</sub> observations with target SpO<sub>2</sub> range 88–92 % were satisfactory with SpO<sub>2</sub> ≥88 % breathing air or SpO<sub>2</sub> 88–92 % breathing oxygen. However, 1.2 % of SpO<sub>2</sub> observations for these patients were too low (<88 %). This was commoner in observations involving use of supplemental oxygen (2.2 %) compared with observations on air (0.9 %).</div><div>Of the SpO<sub>2</sub> observations with target SpO<sub>2</sub> range 88–92 % which were recorded whilst the patient was receiving supplemental oxygen therapy, 9870 had SpO<sub>2</sub> >92 % (over-oxygenated). This represented 9.2 % of all observations for patients with a target range of 88–92 % and 37.0 % of the 26,668 observations involving use of oxygen for these patients. Compared with nasal cannulae, SpO<sub>2</sub> observations involving use of simple masks, Venturi masks and humidified oxygen were more commonly outside of the target range.</div></div><div><h3>Summary</h3><div>We found that excessive oxygen administration was much commoner than insufficient oxygen therapy for hospital patients at risk of hypercapnia. Excessive oxygen use implies an increased risk of harm to these patients, increased cost, and potentially delayed discharges.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":"238 ","pages":"Article 107965"},"PeriodicalIF":3.1000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Are we giving too much oxygen to patients at risk of hypercapnia? Real world data from a large teaching hospital\",\"authors\":\"B Ronan O'Driscoll, Nawar Diar Bakerly\",\"doi\":\"10.1016/j.rmed.2025.107965\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>Oxygen guidelines recommend a target saturation range (SpO<sub>2</sub> range) of 88–92 % for patients at risk of hypercapnia. Saturations <88 % and saturations >92 % whilst using supplemental oxygen are associated with increased mortality.</div></div><div><h3>Methods</h3><div>We audited SpO<sub>2</sub> observations of all patients with a prescribed target range of 88–92 % at one hospital over a four-year period.</div></div><div><h3>Results</h3><div>Of 1,045,958 observations from patients with an oxygen prescription, 107,724 (10.3 %) had a target range of 88–92 % (at risk of hypercapnia). 26,668 of these observations (24.8 %) involved oxygen use. 89.6 % of the SpO<sub>2</sub> observations with target SpO<sub>2</sub> range 88–92 % were satisfactory with SpO<sub>2</sub> ≥88 % breathing air or SpO<sub>2</sub> 88–92 % breathing oxygen. However, 1.2 % of SpO<sub>2</sub> observations for these patients were too low (<88 %). This was commoner in observations involving use of supplemental oxygen (2.2 %) compared with observations on air (0.9 %).</div><div>Of the SpO<sub>2</sub> observations with target SpO<sub>2</sub> range 88–92 % which were recorded whilst the patient was receiving supplemental oxygen therapy, 9870 had SpO<sub>2</sub> >92 % (over-oxygenated). This represented 9.2 % of all observations for patients with a target range of 88–92 % and 37.0 % of the 26,668 observations involving use of oxygen for these patients. Compared with nasal cannulae, SpO<sub>2</sub> observations involving use of simple masks, Venturi masks and humidified oxygen were more commonly outside of the target range.</div></div><div><h3>Summary</h3><div>We found that excessive oxygen administration was much commoner than insufficient oxygen therapy for hospital patients at risk of hypercapnia. Excessive oxygen use implies an increased risk of harm to these patients, increased cost, and potentially delayed discharges.</div></div>\",\"PeriodicalId\":21057,\"journal\":{\"name\":\"Respiratory medicine\",\"volume\":\"238 \",\"pages\":\"Article 107965\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0954611125000277\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611125000277","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Are we giving too much oxygen to patients at risk of hypercapnia? Real world data from a large teaching hospital
Introduction
Oxygen guidelines recommend a target saturation range (SpO2 range) of 88–92 % for patients at risk of hypercapnia. Saturations <88 % and saturations >92 % whilst using supplemental oxygen are associated with increased mortality.
Methods
We audited SpO2 observations of all patients with a prescribed target range of 88–92 % at one hospital over a four-year period.
Results
Of 1,045,958 observations from patients with an oxygen prescription, 107,724 (10.3 %) had a target range of 88–92 % (at risk of hypercapnia). 26,668 of these observations (24.8 %) involved oxygen use. 89.6 % of the SpO2 observations with target SpO2 range 88–92 % were satisfactory with SpO2 ≥88 % breathing air or SpO2 88–92 % breathing oxygen. However, 1.2 % of SpO2 observations for these patients were too low (<88 %). This was commoner in observations involving use of supplemental oxygen (2.2 %) compared with observations on air (0.9 %).
Of the SpO2 observations with target SpO2 range 88–92 % which were recorded whilst the patient was receiving supplemental oxygen therapy, 9870 had SpO2 >92 % (over-oxygenated). This represented 9.2 % of all observations for patients with a target range of 88–92 % and 37.0 % of the 26,668 observations involving use of oxygen for these patients. Compared with nasal cannulae, SpO2 observations involving use of simple masks, Venturi masks and humidified oxygen were more commonly outside of the target range.
Summary
We found that excessive oxygen administration was much commoner than insufficient oxygen therapy for hospital patients at risk of hypercapnia. Excessive oxygen use implies an increased risk of harm to these patients, increased cost, and potentially delayed discharges.
期刊介绍:
Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants.
Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.